Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
As with all incretin-based therapies, retatrutide's side effect profile is closely linked to its receptor pharmacology
Supports dramatic weight loss (up to 24% in trials) Suppresses appetite and prolongs satiety Boosts energy expenditure via glucagon receptor activation Improves glycemic control and insulin sensitivity Reduces liver fat and improves cardiometabolic health May help prevent obesity-related complications What makes Retatrutide different from Semaglutide or Tirzepatide
Over 5 years, 28 participants from the SGLT2i group developed DKA, compared with 11 in the GLP-1 RA group
6 / 7 Shotsy Shotsy was made specifically for people on GLP-1s
Vitex agnus castus essential oil and menopausal balance: a research update [Complementary Therapies in Nursing and Midwifery 8 (2003) 148-154]
Epithalons suppression of HER-2/neu expression is associated with delayed tumor onset, reduced tumor multiplicity, and decreased tumor volume
